Skip to main content

Biological Treatments for Unipolar Depression

An overview of biological interventions for unipolar depression, including antidepressant medications (MAO inhibitors, tricyclics, SSRIs) and brain stimulation therapies (ECT, VNS, TMS, DBS).

Save this reading to your study set

Sign up free

Unipolar depression is a debilitating condition characterized by persistent sadness, loss of energy, low self-worth, and a lack of pleasure. Unlike bipolar disorder, which involves alternating periods of mania and depression, unipolar depression occurs without a history of manic episodes. Because research suggests that biological abnormalities—such as neurotransmitter imbalances and brain circuit dysfunction—play a significant role in the development of this disorder, biological interventions have become a cornerstone of clinical treatment.

Biological treatments for unipolar depression are generally categorized into two primary approaches: antidepressant medications and brain stimulation therapies.

Antidepressant Medications

Diagram illustrating the mechanism of neurotransmitter reuptake inhibition in a synapse, comparing normal reuptake with reuptake inhibited by a drug molecule.
Diagram illustrating the mechanism of neurotransmitter reuptake inhibition in a synapse, comparing normal reuptake with reuptake inhibited by a drug molecule.
Pharmacological interventions aim to correct biochemical imbalances, specifically targeting the activity of key neurotransmitters like serotonin and norepinephrine. By altering how these chemicals interact within the brain, medications can help alleviate the emotional, motivational, and physical symptoms of depression.

Monoamine Oxidase (MAO) Inhibitors

Developed in the 1950s, MAO inhibitors were among the first drugs used to treat depression. These drugs work biochemically by slowing down the body's production of the enzyme monoamine oxidase.

While approximately 50% of patients find relief using this class of medication, they come with significant precautions. Specifically, MAO inhibitors can cause dangerous rises in blood pressure if the patient consumes certain common foods.

Tricyclics

Tricyclic antidepressants act on the neurotransmitter reuptake mechanisms of key neurons. In a healthy brain, neurotransmitters are released into the synapse and then reabsorbed by the sending neuron through a process called reuptake. In many depressed individuals, this process may be overly vigorous. Tricyclics block this reuptake, allowing serotonin and norepinephrine to remain in the synapses longer, thereby increasing their availability to receive signals.

Keep reading for free.

Create an account to finish this reading and make it part of your study routine.

Continue reading free

Already have an account? Log in

Updated

Study it your way.

Import this reading into your study set to get started with another study mode.

Make it your own.

Keep this reading in a new study set, or add it to one you already use.